Literature DB >> 17521846

A new meaning for "Gin & Tonic": tonic inhibition as the target for ethanol action in the brain.

Istvan Mody1, Joseph Glykys, Weizheng Wei.   

Abstract

Gamma-aminobutyric acid (GABA) is the main chemical inhibitory neurotransmitter in the brain. In the central nervous system, it acts on two distinct types of receptor: an ion channel, that is, an "ionotropic" receptor permeable to Cl- and HCO3- (GABAA receptors [GABAARs]) and a G-protein coupled "metabotropic" receptor that is linked to various effector mechanisms (GABAB receptors). This review will summarize novel developments in the physiology and pharmacology of GABAARs, specifically those found outside synapses. The focus will be on a particular combination of GABAAR subunits responsible for mediating tonic inhibition and sensitive to concentrations of ethanol legally considered to be sobriety impairing. Since the same receptors are also a preferred target for the metabolites of steroid hormones synthesized in the brain (neurosteroids), the ethanol-sensitive tonic inhibition may be a common pathway for interactions between the effects of alcohol and those of ovarian and stress-related neurosteroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521846      PMCID: PMC2012942          DOI: 10.1016/j.alcohol.2007.03.009

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  85 in total

1.  GABA uptake regulates cortical excitability via cell type-specific tonic inhibition.

Authors:  Alexey Semyanov; Matthew C Walker; Dimitri M Kullmann
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

2.  Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.

Authors:  Jamie L Maguire; Brandon M Stell; Mahsan Rafizadeh; Istvan Mody
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

Review 3.  Extracellular level of GABA and Glu: in vivo microdialysis-HPLC measurements.

Authors:  Gabriella Nyitrai; Katalin A Kékesi; Gábor Juhász
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

Review 4.  Gaboxadol--a new awakening in sleep.

Authors:  Keith A Wafford; Bjarke Ebert
Journal:  Curr Opin Pharmacol       Date:  2005-12-20       Impact factor: 5.547

5.  Alcohol and presynaptic inhibition in an isolated spinal cord preparation.

Authors:  R A Davidoff
Journal:  Arch Neurol       Date:  1973-01

6.  Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance.

Authors:  S G Brickley; V Revilla; S G Cull-Candy; W Wisden; M Farrant
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

7.  GABAergic neurones in the rat periaqueductal grey matter express alpha4, beta1 and delta GABAA receptor subunits: plasticity of expression during the estrous cycle.

Authors:  J L Griffiths; T A Lovick
Journal:  Neuroscience       Date:  2005-10-13       Impact factor: 3.590

Review 8.  Ethanol and the benzodiazepine-GABA receptor-ionophore complex.

Authors:  M K Ticku
Journal:  Experientia       Date:  1989-05-15

9.  A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.

Authors:  H A Wieland; H Lüddens; P H Seeburg
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

10.  Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex.

Authors:  J N Nestoros
Journal:  Science       Date:  1980-08-08       Impact factor: 47.728

View more
  30 in total

1.  Dihydropyrimidinone positive modulation of delta-subunit-containing gamma-aminobutyric acid type A receptors, including an epilepsy-linked mutant variant.

Authors:  Ryan W Lewis; John Mabry; Jason G Polisar; Kyle P Eagen; Bruce Ganem; George P Hess
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

2.  Charge and geometry of residues in the loop 2 β hairpin differentially affect agonist and ethanol sensitivity in glycine receptors.

Authors:  Daya I Perkins; James R Trudell; Liana Asatryan; Daryl L Davies; Ronald L Alkana
Journal:  J Pharmacol Exp Ther       Date:  2012-02-22       Impact factor: 4.030

3.  Subunit-specific trafficking of GABA(A) receptors during status epilepticus.

Authors:  Howard P Goodkin; Suchitra Joshi; Zakaria Mtchedlishvili; Jasmit Brar; Jaideep Kapur
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

Review 4.  GABAA receptor: Positive and negative allosteric modulators.

Authors:  Richard W Olsen
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

5.  Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity.

Authors:  Daya I Perkins; James R Trudell; Daniel K Crawford; Liana Asatryan; Ronald L Alkana; Daryl L Davies
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

6.  Slow intracellular accumulation of GABA(A) receptor delta subunit is modulated by brain-derived neurotrophic factor.

Authors:  S Joshi; J Kapur
Journal:  Neuroscience       Date:  2009-08-07       Impact factor: 3.590

7.  Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol.

Authors:  M J Ramaker; M M Ford; T J Phillips; D A Finn
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

8.  Novel subunit-specific tonic GABA currents and differential effects of ethanol in the central amygdala of CRF receptor-1 reporter mice.

Authors:  Melissa A Herman; Candice Contet; Nicholas J Justice; Wylie Vale; Marisa Roberto
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

9.  Ethanol selectively attenuates NMDAR-mediated synaptic transmission in the prefrontal cortex.

Authors:  Carl Weitlauf; John J Woodward
Journal:  Alcohol Clin Exp Res       Date:  2008-03-13       Impact factor: 3.455

Review 10.  Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?

Authors:  M Wallner; R W Olsen
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.